FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

20151411000001107: Taurolidine 2g/100ml intraperitoneal solution bottles (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Apr 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68238501000001110 Taurolidine 2g/100ml intraperitoneal solution bottles (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68238601000001114 Taurolidine 2g/100ml intraperitoneal solution bottles en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Taurolidine 2g/100ml intraperitoneal solution bottles Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intraperitoneal route true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solution.intraperitoneal ontology form and route true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has specific active ingredient Taurolidine true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Is a Taurolidine true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has specific active ingredient Taurolidine false Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has active ingredient Anti-infective agent false Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Taurolin 2g/100ml intraperitoneal solution bottles (Imported (Ireland)) Is a True Taurolidine 2g/100ml intraperitoneal solution bottles Inferred relationship Existential restriction modifier
Taurolidine 2g/100ml intraperitoneal solution bottles 1 bottle Has VMP True Taurolidine 2g/100ml intraperitoneal solution bottles Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start